Effectiveness of electroconvulsive therapy in Lance-Adams syndrome.

Brain Stimul

Paris Brain Institute, ICM, Inserm, CNRS, Sorbonne Université, F-75013, Paris, France; AP-HP, Epilepsy Unit, Pitié-Salpêtrière Hospital, Paris, France. Electronic address:

Published: May 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brs.2023.03.004DOI Listing

Publication Analysis

Top Keywords

effectiveness electroconvulsive
4
electroconvulsive therapy
4
therapy lance-adams
4
lance-adams syndrome
4
effectiveness
1
therapy
1
lance-adams
1
syndrome
1

Similar Publications

Background: Electroconvulsive therapy (ECT) is an effective treatment for treatment-resistant depression (TRD). There are limited data on the improvement of anxiety symptoms in patients receiving ECT for TRD.

Objective: The aim of the study was to examine the extent to which anxiety symptom severity improves, relative to improvements in depressive symptoms, in TRD patients receiving an acute course of ECT.

View Article and Find Full Text PDF

There remains a scarcity of studies to evaluate the treatment effect of electroconvulsive therapy (ECT). Functional near-infrared spectroscopy (fNIRS) offers a cost-effective method to measure cerebral hemodynamics. This study used fNIRS to evaluate the effect of ECT in patients suffering from schizophrenia or bipolar disorder (manic phase).

View Article and Find Full Text PDF

Electroconvulsive therapy (ECT) is an effective treatment for severe depression, especially in treatment-resistant cases. However, its potential cognitive side effects necessitate careful dosing to balance therapeutic benefits and cognitive stability. Recent advances in electric field (E-field) modeling offer promising avenues to optimize ECT dosing.

View Article and Find Full Text PDF

Trajectory of peripheral inflammation during index ECT in association with clinical outcomes in treatment-resistant depression.

Brain Behav Immun Health

February 2025

Department of Psychiatry & Biobehavioral Sciences, Jane and Terry Semel Institute for Neuroscience and Human Behavior, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.

Background: Electroconvulsive therapy (ECT) is a highly efficacious intervention for severe and intractable depression. Evidence suggests ECT provokes an initial acute inflammatory response that subsequently decreases with repeated administration. However, relationships between inflammatory changes and clinical effects are unclear.

View Article and Find Full Text PDF

Objective: Evaluation of the effects of electroconvulsive therapy (ECT) on systemic inflammatory markers in patients with severe mental disorders and determination of potential clinical predictors of treatment response.

Methods: The current retrospective cohort study included 156 patients with psychotic and mood disorders who underwent ECT. Pre- and post-ECT blood samples were collected to assess inflammatory markers, including C-reactive protein (CRP), neutrophil-lymphocyte ratio (NLR), and other complete blood count derived indices.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!